Hydrea
Hydrea (Hydroxyurea 500 mg) — BMS ribonucleotide reductase inhibitor for chronic myeloid leukaemia, polycythaemia vera, essential thrombocythaemia, sickle cell disease.
✓ Ιατρικά ελεγμένο από Morgan Ellis — Ερευνητής Φαρμακευτικής · 8 χρόνια εμπειρία · Τελευταία αναθεώρηση: Μάιος 2026
Γρήγορη απάντηση
Hydrea — Hydroxyurea 500 mg (Bristol Myers Squibb). Ribonucleotide reductase inhibitor for chronic myeloid leukaemia (older first-line, now second-line after BCR-ABL TKIs), polycythaemia vera, essential thrombocythaemia, sickle cell disease, refractory cytoreduction.
Αυτό που λαμβάνετε με την MedsBase:
- πιστοποιημένο από τη WHO-GMP κατασκευαστή
- Συσκευασία σε απλό φάκελο χωρίς ενδείξεις
- Παγκόσμια αποστολή
- Αξιολογήθηκε από 1,400+ πελάτες (διαβάστε κριτικές)
📦 Εγγύηση Επαναποστολής: αν η παραγγελία σας δεν έχει φτάσει μέσα σε 20 εργάσιμες ημέρες από την αποστολή, την επαναποστέλλουμε χωρίς πρόσθετο κόστος. Διαβάστε την πολιτική.
Γιατί να παραγγείλετε από τη MedsBase
Hydrea ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.
⚠️ Specialist-supervised cancer therapy — this medication is started, monitored, and stopped by an oncologist or haematologist. Dosing depends on tumour type, stage, body surface area, organ function, and concomitant therapy. Self-treatment is not appropriate; the information below is educational and supports informed conversations with your specialist.
Cumulative myelosuppression — weekly FBC initially. Cutaneous side effects: leg ulcers (especially ankles), nail/skin pigmentation, secondary skin cancers (squamous cell). Avoid in pregnancy (teratogenic) and breastfeeding.
Συχνές Ερωτήσεις
When is this used?
Ribonucleotide reductase inhibitor for chronic myeloid leukaemia (older first-line, now second-line after BCR-ABL TKIs), polycythaemia vera, essential thrombocythaemia, sickle cell disease, refractory cytoreduction. Specific protocols are oncologist-determined.
Παρενέργειες;
Class-typical: myelosuppression, nausea, alopecia, mucositis, fatigue. Specific toxicities depend on the drug — see safety boxes above.
Αλληλεπιδράσεις φαρμάκων;
Cancer chemotherapy has multiple critical interactions. Always disclose all medications including herbals and supplements. Anticoagulants, anticonvulsants, antibiotics, antifungals, and antivirals all need review.
Εγκυμοσύνη;
Cytotoxic chemotherapy is teratogenic. Effective contraception during and for 6 months after for both partners.
Monitoring?
Specialist-determined — typically FBC, renal/liver function, electrolytes before each cycle. Drug-specific tests (echocardiogram for anthracyclines, audiometry for cisplatin, etc.).
Τι γίνεται αν χάσω μια δόση;
Oral cytotoxics: skip the missed dose, do not double up, contact your oncology team. IV: dosing is strictly scheduled — discuss any delay or missed cycle with the specialist.
Storage?
Oral cytotoxics: at room temperature, away from children, in original blister. Hand washing after handling tablets. Pregnant household members should not handle broken tablets.
Vaccines?
Live vaccines are contraindicated during chemotherapy. Inactivated vaccines (annual influenza, pneumococcal) are recommended. Coordinate with oncology for timing.
Long-term complications?
Class-dependent: secondary malignancy, infertility, cardiotoxicity, neuropathy. Discuss with oncology — fertility preservation may be relevant before starting.
When is treatment finished?
Determined by tumour response, treatment intent (curative vs palliative), and toxicity. Imaging and clinical assessment guide ongoing therapy.
Other Cancer Medications
- Xeloda — capecitabine 500 mg — oral 5-FU prodrug for breast/colorectal/gastric cancers
- Altraz — anastrozole 1 mg — aromatase inhibitor for post-menopausal breast cancer
- Xbira — abiraterone 250 mg — CYP17 inhibitor for metastatic prostate cancer
- Zoldria — zoledronic acid IV — for bone metastases and hypercalcaemia
- Actorise — darbepoetin alfa — for chemotherapy-induced anaemia
More options in Anti Cancer Medication
Ταξινομημένα σύμφωνα με τον όγκο παραγγελιών στο MedsBase — τι επιλέγουν άλλοι πελάτες σε αυτήν την κατηγορία.
| Ισχύς | 500 mg |
|---|---|
| Ποσότητα | 30 Καψάκια, 60 Καψάκια, 90 Καψάκια |
| Φαρμακευτική Μορφή | Καψούλα/ες |
| Κατασκευαστής | Sarabhai Chemicals |
| Θεραπεία | Resistant chronic myeloid leukemia |
| Γενόσημη μάρκα | Hydroxyurea |
Hydrea
Ερωτήσεις & Απαντήσεις
Hydrea
Σχετικά προϊόντα
Κριτικές
Δεν υπάρχουν ακόμη κριτικές